BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,584,723 | -17.9% | 51,468 | +3.3% | 0.01% | -16.7% |
Q2 2023 | $3,147,676 | +153.7% | 49,805 | +80.6% | 0.01% | +140.0% |
Q1 2023 | $1,240,734 | +47.0% | 27,578 | +43.2% | 0.01% | +25.0% |
Q4 2022 | $843,869 | -24.9% | 19,262 | +13.0% | 0.00% | -42.9% |
Q3 2022 | $1,123,000 | +30.3% | 17,043 | -0.2% | 0.01% | +16.7% |
Q2 2022 | $862,000 | -16.7% | 17,074 | +5.4% | 0.01% | -14.3% |
Q1 2022 | $1,035,000 | -38.9% | 16,206 | +2.5% | 0.01% | -41.7% |
Q4 2021 | $1,693,000 | +10.9% | 15,805 | +6.5% | 0.01% | -7.7% |
Q3 2021 | $1,526,000 | +40.6% | 14,841 | +20.3% | 0.01% | +30.0% |
Q2 2021 | $1,085,000 | -9.6% | 12,338 | 0.0% | 0.01% | -23.1% |
Q1 2021 | $1,200,000 | -12.3% | 12,338 | +1.1% | 0.01% | -27.8% |
Q4 2020 | $1,369,000 | +13.1% | 12,207 | -5.2% | 0.02% | -10.0% |
Q3 2020 | $1,210,000 | +18.9% | 12,881 | 0.0% | 0.02% | +17.6% |
Q2 2020 | $1,018,000 | +58.1% | 12,881 | +14.2% | 0.02% | +21.4% |
Q1 2020 | $644,000 | -30.1% | 11,281 | +0.7% | 0.01% | -6.7% |
Q4 2019 | $921,000 | – | 11,201 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |